Pharmiwebcom

30/01/2024

Gilead and Arcus Announce Amended Collaboration and Equity Investment

Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced an amendment to their collaboration agreement and a separate equity investment by Gilead of $320 million in Arcus common stock at $21.00 per share. The equity investment and collaboration amendment ...

29/01/2024

PharmiWeb Unveils New Branding in Celebration of 25th Anniversary

PharmiWeb, the leading global life science news and jobs portal, is excited to unveil its new branding in line with the company’s 25th anniversary celebrations. This fresh visual identity symbolises PharmiWeb’s commitment to continuous evolution, and to creating a standout user experience for .....

29/01/2024

Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid ...

26/01/2024

AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site

AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global ...

25/01/2024

According to Germany Trade & Invest (GTAI), constitutes the major European market and the fourth largest worldwide, with a pharmaceutical market that is growing at a faster rate than the German economy.

The country is home to more than 600 pharmaceutical companies, with the pharma industry employing around 140,000 people. In this article, we highlight the top 10 and companies in Germany as of 2023, based on their market capitalisation.

The country is home to more than 600 pharmaceutical companies, with the pharma industry employing around 140,000 people. In this article, we highlight the top 10 biotech and pharma companies in Germany as of 2023, based on their market capitalisation.

25/01/2024

New ICON survey highlights importance of combination therapies in future obesity treatment

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeutic ...

24/01/2024

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® (“Mirati”). With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary ...

23/01/2024

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics, a software company accelerating precision medicine research, has raised $11.4 million in new funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp. Founded by Patrick Short (CEO), Charlotte Guzzo (COO) and William Jones ...

22/01/2024

Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (AIFA) allowing the company to manufacture RNA-based products at its Monza, Italy site. The approval and associated certification support ...

19/01/2024

Influx of promotions and new starters at Cellomatics signals next successful phase for award winning business

Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals ...

18/01/2024

Global Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development

Boehringer’s employer offerings receive particularly high scores in the categories “Develop” and “Steer” pointing out a link between individual development and the company purpose of transforming lives for generations. The internal Boehringer Ingelheim University is a key element in this. ...

17/01/2024

Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy, for the treatment of transfusion-dependent beta thalassemia (TDT) in patients 12 ....

16/01/2024

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection. Last year, more than 38,000 people in ...

12/01/2024

Have you caught up with what's been happening in the industry?

Here's some of the biggest news we've seen this week:

🎁 PharmiWeb Celebrates its 25th Anniversary (of course we had to be on the list!): https://phrmwb.com/3RWhqNZ
💰 Biotech Companies to Increase R&D Spend but Highlight Complexity of Clinical Trials: https://phrmwb.com/3Hk4X1P
🤝 GSK Enters Agreement to Acquire Aiolos Bio: https://phrmwb.com/3O0ddru
🔬 Boehringer Ingelheim Enters 2024 on a High Note - Announcing Five New R&D Partnerships: https://phrmwb.com/3TYOasC
🤝 Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline: https://phrmwb.com/3O3325A

12/01/2024

Boehringer expands production site in Greece for new medicine

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications, some of them in ...

11/01/2024

As we celebrate PharmiWeb turning 25, we’ve been reflecting on just how much the industry has transformed over the past quarter century, and imagining what it will look like in another 25 years’ time.

In this article, we’ve rounded up some of the most significant predictions on what life sciences could look like by 2050, with insights presented by futurologists and industry experts.

https://phrmwb.com/48P0Who

#2050

As we celebrate PharmiWeb turning 25, we’ve been reflecting on just how much the life science industry has transformed over the past quarter century, and imagining what it will look like in another 25 years’ time.

10/01/2024

Boehringer Ingelheim enters 2024 on a high note: Announcing five new R&D partnerships

Boehringer Ingelheim has kicked off 2024 on a high note by announcing that the company is entering five new R&D partnerships to further enable and accelerate the company’s commitment to transform the lives of patients world-wide. Through these strategic partnerships, Boehringer is building on ...

09/01/2024

PharmiWeb Celebrates its 25th Anniversary

PharmiWeb, the leading global life science news and jobs portal, is excited to announce it will be celebrating its 25th anniversary this month. To commemorate this significant milestone, PharmiWeb will be running a month-long celebration campaign throughout January, recognising the company’s ...

09/01/2024

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech funding” whitepaper. This provides an overview of the current state of play for biotech companies and the research and development (R&D) strategies they can...

08/01/2024

Thermo Fisher Scientific Launches PangenomiX Array to Support Population-Scale Disease Studies and Pharmacogenomics Research

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more diverse representation of the human genome1. To more accurately account for this richer picture of human genomic variation, Thermo Fisher ...

05/01/2024

Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™

Eli Lilly and Company (NYSE: LLY) today announced LillyDirect™, a new digital healthcare experience for patients in the U.S. living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to independent healthcare providers*, tailored support, and ...

04/01/2024

Happy New Year from all of us at PharmiWeb!

We're well into our planning for 2024, and as part of that, we've compiled this list of recognition and awareness days taking place this year:

https://phrmwb.com/3H8jAW0

Know of one that's not on the list? Let us know!

Here, we’ve compiled a list of life science recognition and awareness days taking place in 2024.

04/01/2024

Calibre Scientific Acquires LineaLAB

Calibre Scientific has acquired LineaLAB, SL, a provider of analytical, bio and laboratory equipment based in Badalona (Barcelona). LineaLAB is Calibre Scientific’s fourth acquisition in Spain, further bolstering its position as one of the leading providers of laboratory products and services ...

03/01/2024

Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases

Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) today announced a collaboration with Boehringer Ingelheim to develop novel treatments for nonalcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH). The partnership brings together Ribo’s leading ...

19/12/2023

ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023

In recognition of its Environmental, Social and Governance (ESG) efforts and as an employer of choice, ICON ranked 88th in TIME’s list of the World’s Best Companies of 2023, the highest ranking CRO within the top 750 companies included. The award evaluates companies using standardised KPIs on .....

18/12/2023

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data. In a preprint paper published on bioRxiv ...

15/12/2023

Pfizer Completes Acquisition of Seagen

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of ...

14/12/2023

Merck Ranks No. 1 on Newsweek’s List of

America’s Most Responsible Companies 2024

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has earned the top spot on Newsweek’s annual list of America’s Most Responsible Companies, ranking No. 1 overall for the first time and establishing itself as an industry leader for the second consecutive year. Notably ...

13/12/2023

During the PHARMAP 2024 in Amsterdam, the Netherlands, on 22-23 April delegates take part in the roundtable dedicated to advancing sustainability in the pharmaceutical industry. The format of the roundtable includes a limited number of participants, where some speakers present their reports and have a discussion with the audience. The discussions cover the topics of environmental, social, and economic aspects of sustainability throughout the pharmaceutical value chain.

Among the audience of the roundtables are:

● pharmaceutical companies and associations;
● environmental and CSR professionals;
● technology providers and equipment manufacturers;
● government and regulatory bodies.

Join the roundtable at PHARMAP 2024: https://phrmwb.com/47W3daO

13/12/2023

Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

Pfizer Inc. (NYSE: PFE) today announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired December 11, 2023, with respect to Pfizer’s pending acquisition of Seagen Inc. (NASDAQ: SGEN). Pfizer and Seagen have now received all required ...